AN2 Therapeutics (ANTX) Income Statement (2021 - 2026)
Income Statement report data from Mar 31, 2021 to Mar 31, 2026 for AN2 Therapeutics (ANTX).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||
Total Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | 630K (+34.04%) | 470K (+104.35%) | 230K (+666.67%) | 30K (0.00%) | 30K (0.00%) | 30K (+50.00%) | 20K | - |
Operating Expenses | |||||||||||||||||||||
Research And Development | 6.74M (-2.03%) | 6.88M (-1.71%) | 7.00M (+118.75%) | 3.20M (-58.39%) | 7.69M (+42.41%) | 5.40M (-34.86%) | 8.29M (-31.77%) | 12M (-17.12%) | 15M (-1.74%) | 15M (+3.40%) | 14M (+6.57%) | 14M (+12.93%) | 12M (+37.03%) | 8.75M (+17.77%) | 7.43M (+10.90%) | 6.70M (+19.01%) | 5.63M (+6.03%) | 5.31M (-0.75%) | 5.35M (+38.96%) | 3.85M (+133.33%) | 1.65M |
Selling General And Administrative | 3.81M (+56.15%) | 2.44M (-19.74%) | 3.04M (-24.38%) | 4.02M (+4.42%) | 3.85M (+19.94%) | 3.21M (-7.76%) | 3.48M (-6.70%) | 3.73M (+2.47%) | 3.64M (-6.67%) | 3.90M (+4.00%) | 3.75M (+22.55%) | 3.06M (-24.44%) | 4.05M (+8.87%) | 3.72M (+11.38%) | 3.34M (-8.24%) | 3.64M (+77.56%) | 2.05M (+15.17%) | 1.78M (+11.95%) | 1.59M (+76.67%) | 900K (+125.00%) | 400K |
Operating Expenses | 11M (+13.20%) | 9.32M (-7.17%) | 10M (+39.06%) | 7.22M (-37.44%) | 12M (+34.19%) | 8.60M (-38.62%) | 14M (-11.78%) | 16M (-13.22%) | 18M (-2.76%) | 19M (+3.52%) | 18M (+9.52%) | 17M (+3.49%) | 16M (+28.53%) | 12M (+6.03%) | 12M (+13.94%) | 10M (+34.51%) | 7.68M (+1.19%) | 7.59M (+9.52%) | 6.93M (+38.60%) | 5.00M (+143.90%) | 2.05M |
Operating Income | |||||||||||||||||||||
Operating Income | -10.55M (+13.20%) | -9.32M (-7.17%) | -10.04M (+39.06%) | -7.22M (-37.44%) | -11.54M (+34.19%) | -8.60M (-38.62%) | -14.01M (-11.78%) | -15.88M (-13.22%) | -18.30M (-2.76%) | -18.82M (+3.52%) | -18.18M (+9.52%) | -16.60M (+3.49%) | -16.04M (+28.53%) | -12.48M (+6.03%) | -11.77M (+13.94%) | -10.33M (+34.51%) | -7.68M (+1.19%) | -7.59M (+9.52%) | -6.93M (+38.60%) | -5.00M (+143.90%) | -2.05M |
Ebit | -10.55M (+13.20%) | -9.32M (-7.17%) | -10.04M (+39.06%) | -7.22M (-37.44%) | -11.54M (+34.19%) | -8.60M (-38.62%) | -14.01M (-11.78%) | -15.88M (-13.22%) | -18.30M (-2.76%) | -18.82M (+3.52%) | -18.18M (+9.52%) | -16.60M (+3.49%) | -16.04M (+28.53%) | -12.48M (+6.03%) | -11.77M (+13.94%) | -10.33M (+34.51%) | -7.68M (+1.19%) | -7.59M (+9.52%) | -6.93M (+38.60%) | -5.00M (+143.90%) | -2.05M |
EBITDA | -10.03M (+15.15%) | -8.71M (-6.84%) | -9.35M (+44.74%) | -6.46M (-39.34%) | -10.65M (+41.62%) | -7.52M (-41.02%) | -12.75M (-11.64%) | -14.43M (-13.18%) | -16.62M (-1.66%) | -16.90M (+1.14%) | -16.71M (+5.76%) | -15.80M (+3.13%) | -15.32M (+29.39%) | -11.84M (+4.41%) | -11.34M (+12.06%) | -10.12M (+32.29%) | -7.65M (+1.46%) | -7.54M (+8.65%) | -6.94M (+38.52%) | -5.01M (+144.39%) | -2.05M |
Other Income / Expenses | |||||||||||||||||||||
Interest Income | 520K (-14.75%) | 610K (-11.59%) | 690K (-8.00%) | 750K (-15.73%) | 890K (-17.59%) | 1.08M (-14.96%) | 1.27M (-12.41%) | 1.45M (-13.69%) | 1.68M (-65.43%) | 4.86M | - | - | - | - | - | - | - | - | - | - | - |
Net Interest Income | 520K (-14.75%) | 610K (-11.59%) | 690K (-8.00%) | 750K (-15.73%) | 890K (-17.59%) | 1.08M (-14.96%) | 1.27M (-12.41%) | 1.45M (-13.69%) | 1.68M (-65.43%) | 4.86M | - | - | - | - | - | - | - | - | - | - | - |
Other Non Operating Income | - | - | - | - | - | - | 1.27M | - | - | 40K (-97.28%) | 1.47M (+83.75%) | 800K (+11.11%) | 720K (-45.04%) | 1.31M (+204.65%) | 430K (+104.76%) | 210K (+600.00%) | 30K | -40.00K (0.00%) | -40.00K (+100.00%) | -20.00K | - |
Net Income | |||||||||||||||||||||
Net Income From Continuing Operations | -10.03M (+15.15%) | -8.71M (-6.84%) | -9.35M (+44.74%) | -6.46M (-39.34%) | -10.65M (+41.62%) | -7.52M (-41.02%) | -12.75M (-11.64%) | -14.43M (-13.18%) | -16.62M (-1.66%) | -16.90M (+1.14%) | -16.71M (+5.76%) | -15.80M (+3.13%) | -15.32M (+29.39%) | -11.84M (+4.41%) | -11.34M (+12.06%) | -10.12M (+32.29%) | -7.65M (+1.46%) | -7.54M (+8.65%) | -6.94M (+38.52%) | -5.01M (+144.39%) | -2.05M |
Net Income | -10.03M (+15.15%) | -8.71M (-6.84%) | -9.35M (+44.74%) | -6.46M (-39.34%) | -10.65M (+41.62%) | -7.52M (-41.02%) | -12.75M (-11.64%) | -14.43M (-13.18%) | -16.62M (-1.66%) | -16.90M (+1.14%) | -16.71M (+5.76%) | -15.80M (+3.13%) | -15.32M (+29.39%) | -11.84M (+4.41%) | -11.34M (+12.06%) | -10.12M (+32.29%) | -7.65M (+1.46%) | -7.54M (+8.65%) | -6.94M (+38.52%) | -5.01M (+144.39%) | -2.05M |
Comprehensive Income Net Of Tax | -10.09M (-71.29%) | -35.15M (+277.55%) | -9.31M (+43.67%) | -6.48M (-39.04%) | -10.63M (-79.38%) | -51.56M (+308.88%) | -12.61M (-13.09%) | -14.51M (-13.84%) | -16.84M (-73.72%) | -64.08M (+283.48%) | -16.71M (+6.10%) | -15.75M (+4.17%) | -15.12M (-63.39%) | -41.30M (+258.51%) | -11.52M (+11.63%) | -10.32M (+32.48%) | -7.79M (-63.89%) | -21.57M (+210.36%) | -6.95M (+38.72%) | -5.01M (+144.39%) | -2.05M |